Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
DOI 10.1007/s00264-011-1414-4
REVIEW ARTICLE
Received: 30 October 2011 / Accepted: 2 November 2011 / Published online: 25 November 2011
# Springer-Verlag 2011
Abstract
Purpose The objective of this systematic review was to
characterise the methodological issues, as well as clinical,
diagnosis, microbiological and treatment characteristics of
patients with spinal tuberculosis.
Methods We conducted a systematic review including
prospective or retrospective case series written in English,
Spanish, French, German and Italian published in the
period from January 1980 to March 2011.
Results Thirty-seven articles were included with a total of
1,997 patients; the median of the percentage of men was
53% (interquartile range [IQR] 4864) and the median of
the patients mean age was 43.4 (IQR 3755). The most
common symptom reported was back pain, and thoracic
spine was the most frequent segment involved. Spinal plain
radiography was done in 35 studies (94.6%), magnetic
resonance imaging (MRI) in 26 (70.2%), computed
tomography scan (CT-scan) in 13 (35%) and microbiological
diagnosis in 29 (78.3%). Surgical treatment was
reported in 28 articles 75.7%; finally, 24 articles
reported follow-up, and in 15 of them at least 80% of
patients improved.
Conclusions Spinal TB is still an important public health issue,
it must be suspected in the presence of back pain or
characteristic images and should be confirmed with microbiological procedures. Chemotherapy treatment is often used; in
contrast, there is heterogeneity in the percentage of patients
treated by surgery.
Introduction
Tuberculosis (TB) is caused by Mycobacterium tuberculosis,
and is one of the oldest disease in the world. It has been
described in almost all ancient civilisations, and tuberculous
bacilli has even been found in prehistoric skeletal remains [1].
The disease has been an important public health issue,
having serious medical, social and financial impacts, especially
in developing countries. TB incidence has been rising since the
1980s and early 1990s, causing 23 million deaths annually
worldwide [2]. Despite a marked improvement in the
socioeconomic status of many countries and the availability
of effective antitubercular drugs, the impact of the acquired
immunodeficiency syndrome (AIDS) pandemic and immigration have increased the rate of the disease [3]. Immigrants
have not been diagnosed in their own countries or have not
been fully treated, which make them infective, which is why
tuberculosis is a world-wide public health problem [4].
Extra-pulmonary TB accounts for about 1520% of TB
cases [5]. Although the true incidence of spinal TB is not
certain, it has been estimated that it occurs in 1.7% of the
world population. Vertebral tuberculosis is the most common
form of skeletal tuberculosis, constituting approximately
50% of all cases [6].
Spinal tuberculosis was discovered by Pott in 1776 and
is the result of haematogenous dissemination from a
primary focus. The infection reaches the skeletal system
through vascular channels, generally the arteries, as a result
of bacillemia, or rarely in the axial skeleton through
Batsons plexus of veins [1]. The infection spreads to the
adjacent vertebral bodies under the longitudinal ligaments.
The most common site is the thoracolumbar junction, but
any segment of the spine can be involved; nevertheless, TB
of the cervical region accounts for 10% of all cases of spinal
TB. Atlantoaxial junctions are the least common sites for
222
Results
Selected papers
The database search identified 5,576 titles (MEDLINE
(PubMed), 1,522 titles; EMBASE, 2,086 titles; CINAHL,
968 titles; and ISI Web of Sciences, 1,000 titles). Combining
the results of the four electronic searches and removing
duplicate records left titles of 2,605 unique records to be
screened independently. Screening of the titles and abstracts
Epidemiology
Table 2 shows the epidemiological features of the included
studies. The median of the patients mean age of all studies
was 43.4 (interquartile range [IQR] 3755), and the age
range was nine to 76 years old. The median of the percentage of
men was 53% (IQR 4864). In 14 (37.8%) studies were no data
223
on time to diagnosis, and in the rest the mean was 6.5 months
(standard deviation [SD] 2.5) and the range was 312.
Human Immunodeficiency Virus (HIV) test was not
performed in 19 (51.3%) studies and two studies excluded
HIV patients. Only 12 studies had information about
previous treatment or diagnosis of pulmonary TB. A total
of 78.4% (29) of the articles did not report the proportion of
spinal TB in patients with a diagnosis of TB; however, of
the reported cases the highest prevalence was 5.3%. On the
other hand, six (16.2%) studies reported the percentage of
spinal TB in patients with extra pulmonary TB and the
range varied from 1.3 to 17.3%.
Diagnosis procedures and microbiological features
Clinical diagnosis of spinal TB was not present in five
(13.5%) articles as inclusion criteria. Spinal plain
radiography was performed in 94.6% (35) of the
studies. More than 20% of the patients showed normal
results in only four of the studies
In addition to radiography, MRI as a diagnostic test was
performed in 26 (70.2%) articles, and a positive or altered
result greater than 95% was obtained in 77.7% of the
articles. CT scan was used in 13 studies where 61.5%
(eight) showed a positive result greater than or equal to
224
Table 1 Methodological features of included articles
Author
Year
publication
Country
Study
period
Number of
hospital
settings
Number
of patients
1989
Burkina Faso
19861987
45
1989
1991
Peru
Tanzania
19841986
19871988
2
1
27
47
1993
Canada
19811990
1993
Spain
19821991
14
1996
EEUU
19881995
1999
France
19801994
103
1999
2000
France
Saudi Arabia
19901997
19851998
2
1
16
69
2001
Nigeria
19901999
50
2001
2001
Spain
Malaysia
19931999
19941998
1
1
14
53
2002
Spain
19861999
37
2002
2003
2003
Tunisia
Senegal
Malaysia
19891999
19861998
20002002
1
3
1
29
255
33
Colmenero et al.[12]
Schlesinger et al.[13]
Lpez Cordoba et al. [46]
2004
2005
2005
Spain
EEUU
Colombia
19832002
19941999
19942004
78
1
1
12
35
2005
2006
2006
France
Iran
Turkey
19862003
19962005
19972003
1
2
1
24
118
40
2007
2007
Turkey
Korea
19902005
19942003
1
7
44
137
2008
2008
2009
South Africa
Japan
UK
20052006
19902002
19992009
1
1
1
104
23
17
2009
2010
2010
South Africa
Nigeria
Taiwan
20012006
20052009
20022008
1
4
1
16
87
48
2010
2010
2010
2010
2010
2010
2011
Taiwan
Morocco
Seoul
Kenya
Iran
Spain
Morocco
19982007
20012006
20032007
20042009
19992008
20002009
20022006
1
1
1
1
1
1
1
38
37
47
129
69
6
82
95%. A total of 29 (78.3%) studies performed microbiological diagnosis. The culture test results were positive
above 70% in 45.4% of the cases (Table 3).
Clinical features
The most common symptom was back pain reported in up
to 80% of patients in 86.6% of the studies while cough,
fever, night sweats and weight loss were less frequently
225
34 ()
-
178
0.514
26 (58)
14 (52)
8 ()
084
52 ()
58 ()
43 (15)
12b
6 (4)
3 ()
4 ()
0/2 (0)
1 (14)
41b
42 ()
53 ()
2 (29)
10 (71)
5 (71)
68 (66)
530
2674
2185
2463
1784
024
036
7/7 (100)
0/54 (0)
8 (57)
19 (18)
2076
1580
9 (56)
37 (53)
3 ()
-
16
-
0/16 (0)
-
5 (7)
27 (23)
270
24 (48)
58 ()
40 ()
9 (64)
37 (70)
7 ()
1 36
-
1/14 (7)
-
2482
19 (51)
7 (7)
132
Excluded
8 (22)
49 ()
35 ()
34 ()
180
376
14 (48)
136 (53)
24 (73)
7 ()
11 ()
-
1120
-
1/37 (3)
-
49 (19)
40 ()
1484
1967
40 (51)
7 (58)
6 ()
-
07
248
6 (8)
1/12 (8)
61 ()
171
-
23 (49)
9 (38)
9 ()
4 ()
160
112
0/24 (0)
0 (0)
4/24 (17)
29 (24)
45 (19)
42 ()
473
1880
1070
82 (70)
20 (50)
21 (48)
12 (12)
-
128
-
44 (17)
28 ()c
76 ()
7092
69 (50)
43 (42)
10 (44)
29 ()
34 (21)
1465
1268
8 (47)
7 (44)
5 ()
7b ()
-
124
024
-
29/104 (28)
1/12 (8)
104 (100)
-
41 (15)
64 (16)
68 ()
9 ()
56 ()
34 (16)
44 (18)
54 ()
1570
1088
3686
415
381
-
57 (66)
24 (50)
23 (61)
24 (64)
17 (36)
68 (53)
42 (61)
2 (33)
75 %>2 months
7 (6)
3 ()
9 ()
4 ()
7 (4)
7 ()
124
024
048
120
15/87 (17)
1 (2)
Excluded
0 (0)
12/69 (17)
2/6 (33)
10 (12)
4 (8)
2 (5)
0 (0)
6 (13)
-
43 ()
473
38 (46)
10 ()
Treatment
The duration of drug treatment varied from six to 18 months,
and it was not specified in 43.2% of the articles. Patients drug
treatment resistances were only recorded in four studies. In 28
226
0/45 (0)
0/27 (0)
14/27 (52)
4/4 (100)
2/7 (29)
1/1 (100)
7/7 (100)
6/6 (100)
5/5 (100)
4/5 (80)
8/8 (100)
2/7 (29)
6/103 (6)
44/44 (100)
3/7 (43)
63/63 (100)
6/7 (86)
66/70 (94)
7/7 (100)
86/103 (84)
5/7 (71)
51/73 (70)
2/15 (13)
5/5 (100)
11/14 (79)
6/14 (43)
1/69 (1.4)
69/69 (100)
69/69 (100)
25/50 (50)
35/50 (70)
6/25 (24)
-
18/27 (67)
7/14 (50)
5/8 (63)
11/15 (73)
0/53 (0)
53/53 (100)
18/18 (100)
8/8 (100)
28/37 (76)
29/37 (78)
7/16 (44)
0/29 (0)
26/26 (100)
17/29 (59)
1/17 (6)
12/255 (5)
11/78 (14)
42/44 (96)
2/2 (100)
58/61 (95)
72/91 (82)
54/65 (83)
35/37 (56)
3/8 (38)
10/13 (77)
-
12/12 (100)
17/17 (100)
10/24 (42)
5/19 (26)
8/12 (67)
5/12 (42)
14/15 (93)
9/11 (82)
13/35 (37)
8/20 (40)
3/12 (25)
14/35 (40)
3/20 (15)
78/118 (66)
12/22 (55)
13/22 (59)
26/34 (76)
35/44 (80)
75/128 (59)
-
35/44 (80)
75/128 (59)
-
19/44 (43)
-
0/23 (0)
1/16 (6)
23/23 (100)
17/17 (100)
16/16 (100)
1/3 (33.3)
13/17 (77)
8/15 (53)
23/23 (100)
11/15 (73)
20/87 (23)
-
16/16 (100)
35/35 (100)
58/67 (87)
-
19/45 (42)
24/38 (63)
11/45 (24)
32/38 (84)
13/69 (19)
0/6 (0)
-
10/10 (100)
13/13 (100)
4/6 (67)
-
28/37 (76)
13/129 (10)
3/6 (50)
26/70 (37)
41/45 (91)
6/69 (9)
6/6 (100)
4/30 (13)
7/7 (100)
41/45 (91)
27/69 (39)
4/6 (67)
6/14 (43)
Discussion
It is estimated that almost six billon people are infected with TB
and over nine million new cases of active TB occur annually with
two to three million deaths [4]. Extra pulmonary TB accounts for
about 1520% of all cases and nearly 13% of patients suffering
from TB have involvement of the skeletal system [1]. In our
12 (44)
28 (53)
100 (97)
13 (81)
58 (84)
14 (100)
35 (45)
29 (100)
232 (91)
68 (99)
6 (100)
81 (9)
38 (100)
100 (78)
46 (96)
Su et al. [16]
79 (91)
13 (76)
41 (87)
19 (83)
44 (100)
37 (93)
107 (90)
24 (100)
27 (77)
34 (41)
1 (17)
18 (26)
13 (28)
37 (77)
87 (100)
12 (75)
4 (24)
13 (57)
4 (33)
65 (83)
9 (75)
202 (80)
24 (83)
11 (30)
50 (94)
33 (89)
2 (13)
51 (50)
2 (29)
7 (50)
3 (43)
7 (100)
14 (100)
40 (85)
7 (100)
3 (11)
Neurological
deficits, n (%)
Back pain,
n (%)
Author
9 (7)
20 (23)
2 (5)
36 (31)
6 (50)
11 (23)
Cough,
n (%)
2 (33)
18 (26)
8 (17)
37 (100)
6 (16)
19 (40)
40 (46)
6 (35)
7 (30)
18 (45)
83 (71)
9 (38)
9 (26)
27 (35)
236 (93)
17 (59)
7 (19)
20 (38)
1 (7)
22 (32)
7 (44)
32 (31)
5 (71)
2 (29)
17 (36)
7 (26)
Fever,
n (%)
12 (17)
24 (19)
37 (100)
6 (35)
11 (28)
236 (93)
20 (38)
15 (22)
19 (18)
2 (29)
6 (13)
Night sweats,
n (%)
81 (99)
10 (15)
9 (7)
37 (100)
3 (8)
4 (8)
18 (21)
13 (33)
83 (71)
10 (42)
8 (23)
236 (93)
18 (49)
19 (28)
49 (48)
4 (57)
5 (71)
11 (23)
Weight loss,
n (%)
29 (33)
22 (55)
153 (60)
31 (45)
Back swelling,
n (%)
0 (0)
7 (6)
4 (9)
2 (5)
1 (2)
2 (4)
0 (0)
3 (18)
1 (4)
11(11)
2 (2)
4 (10)
4 (3)
2 (8)
1 (3)
1 (8)
3 (4)
13 (5)
1 (3)
13 (8)
1 (7)
2 (8)
4 (6)
6 (21)
12 (12)
0 (0)
2 (14)
1 (14)
6 (13)
2 (7)
1 (2)
Cervical,
n (%)
34 (41)
3 (50)
10 (15)
49 (43)
18 (38)
5 (14)
14 (37)
16 (33)
39 (58)
16 (100)
11 (65)
11 (48)
44 (42)
31 (78)
16 (36)
20 (50)
69 (51)
12 (50)
10 (29)
3 (25)
32 (41)
132 (54)
31 (84)
93 (57)
7 (50)
6 (24)
38 (55)
14 (48)
48 (47)
5 (71)
2 (14)
0 (0)
40 (87)
17 (63)
11 (24)
Thoracic,
n (%)
0 (0)
10 (9)
3 (8)
8 (17)
0 (0)
14 (81)
7 (30)
10 (10)
9 (11)
18 (41)
0 (0)
4 (33)
11 (14)
36 (14)
0 (0)
1 (7)
6 (24)
0 (0)
0 (0)
2 (14)
2 (29)
26 (58)
Thoracolum
bar, n (%)
43 (52)
3 (50)
42 (37)
25 (53)
23 (62)
15 (39)
20 (42)
19 (28)
7 (41)
5 (22)
31 (30)
37 (45)
10 (23)
33 (83)
45 (46)
13 (54)
7 (20)
3 (25)
25 (32)
53 (22)
8 (22)
53 (33)
3 (21)
11 (44)
25 (36)
6 (21)
68 (66)
2 (29)
7 (50)
2 (29)
40 (87)
8 (30)
6 (13)
Lumbar,
n (%)
0 (0)
3 (3)
4 (11)
2 (4)
9 (13)
5 (5)
2 (2)
0 (0)
3 (9)
1 (8)
5 (6)
9 (4)
11 (30)
4 (2)
2 (14)
0 (0)
3 (10)
5 (5)
1 (14)
1 (2)
Lumbo sacral,
n (%)
228
Duration of chemotherapy,
(months) mean (SD)
Surgical
treatment, n (%)
Follow-up evaluation
(months), mean (SD)
Clinical improvement,
n (%)a
Lost follow-up,
n (%)
8 (minimum)
45/45 (100)
0 (0)
6 (22)
12 (minimum)
5 (71)
3 ()
50 ()
5/5 (100)
2 (29)
5 (36)
12 ()
14b
-
2 (29)
25 (24)
12 ()
10b
6/7 (86)
46/47 (98)
0 (0)
56 (54)
3 (19)
32 (46)
6 (minimum)
14/14 (100)
32/33 (96)
2 (13)
-
5 (6)
4 (85)
9 ()
12 ()
9 (64)
30 (57)
22 ()
60 ()
50/53 (94)
0 (0)
11 (4)
12 (32)
7 ()
13/36 (36)
1 (3)
15 ()
9 (minimum)
39 (15)
20 (61)
16 ()
5 ()
-
26/29 (90)
118/148 (80)
-
0 (0)
107 (42)
-
12 ()
55 (71)
10 (83)
12 ()
-
12/12 (100)
0 (0)
29 (83)
34 (85)
27/40 (68)
612
-
98 (72)
-
42/44 (95)
94/116 (81)
-
12 ()
12 ()
9 (minimum)
2 (9)
16 (100)
2
-
13/17 (77)
15/16 (94)
0 (0)
8 (minimum)
11 (4)
11b
12 ()
9 ()
12 ()
30 (63)
32 (84)
7 (19)
40 (85)
33 (26)
22 (32)
3 (50)
6 (minimum)
11
11
3
6
12
20/67 (30)
26/37 (70)
24/34 (71)
37/37 (100)
91/129 (70)
53/69 (77)
5/6 (83)
20 (23)
11 (23)
4 (11)
12 (9)
0 (0)
0 (0)
59 (72)
78/82 (95)
SD standard deviation
a
229
230
References
1. Tuli SM (2007) Tuberculosis of the spine: a historical review. Clin
Orthop Relat Res 460:2938
2. Ruiz Manzano J (2000) Tuberculosis and immigration. Med Clin
(Barc) 114:257258
3. Mulleman D, Mammou S, Griffoul I, Avimadje A, Goupille P,
Valat JP (2006) Characteristics of patients with spinal tuberculosis
in a French teaching hospital. Joint Bone Spine 73:424427
4. WHO (1998) Report on the global tuberculosis. The World Health
Report. WHO, pp 251
5. Polley P, Dunn R (2009) Noncontiguous spinal tuberculosis:
incidence and management. Eur Spine J 18:10961101
6. Tuli SM (2002) General principles of osteoarticular tuberculosis.
Clin Orthop Relat Res 1119
7. Khorvash F, Javadi AA, Izadi M, Jonaidi JN, Ranjbar R (2007)
Spinal tuberculosis: a major public health hazard in Isfahan. Pak J
Biol Sci 10:34003404
8. Almeida A (2005) Tuberculosis of the spine and spinal cord. Eur J
Radiol 55:193201
9. Jain AK (2007) Tuberculosis of the spine. Clin Orthop Relat Res
460:23
10. Barriere V, Gepner P, Bricaire F, Bletry O, Caumes E (1999)
Current aspects of spinal tuberculosis: apropos of 16 case reports.
Ann Med Interne (Paris) 150:363369
11. Rasit AH, Razak M, Ting FS (2001) The pattern of spinal
tuberculosis in Sarawak General Hospital. Med J Malaysia
56:143150
12. Colmenero JD, Jimnez-Mejas ME, Reguera JM, Palomino-Nics
J, Ruiz-Mesa JD, Mrquez-Rivas J et al (2004) Tuberculous
vertebral osteomyelitis in the new millennium: still a diagnostic
and therapeutic challenge. Eur J Clin Microbiol Infect Dis
23:477483
13. Schlesinger N, Lardizabal A, Rao J, Rao J, McDonald R (2005)
Tuberculosis of the spine: experience in an inner city hospital. J
Clin Rheumatol 11:1720
14. Park DW (2007) Outcome and management of spinal tuberculosis
according to the severity of disease: a retrospective study of 137
adult patients at Korean teaching hospitals. Spine (Phila Pa 1976)
32:E130E135
231
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.